SEC 13F Intelligence

Managers / Q1 2025 · view latest →

Duquesne Family Office LLC

CIK 0001536411 · Part of the Duquesne family · 40 WEST 57TH STREET, 25TH FLOOR, NEW YORK, NY, 10019 · (212) 830-6500

Reported Value
$3.1B
Q1 2025
Positions
52
Filings on Record
32
2019–present window
Filed
May 15, 2025
original filing

Summary

Duquesne Family Office LLC reported $3.1B in U.S.-listed holdings across 52 positions for Q1 2025.

Its largest position, NTRA, represents 15.7% of the portfolio.

Compared with Q4 2024, the fund opened 12 new positions and exited 37.

Portfolio Metrics

Turnover
+22.6%
vs prior filed quarter
Top-10 Concentration
+59.8%
share of reported value
Largest Position
+15.7%
Natera
New / Exited
12 / 37
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.7BQ4 ’18Q1 ’19: $3.4BQ2 ’19: $3.4BQ3 ’19: $2.6BQ4 ’19: $3.4BQ4 ’19Q1 ’20: $2.5BQ2 ’20: $3.3BQ3 ’20: $3.4BQ4 ’20: $3.7BQ4 ’20Q1 ’21: $4.5BQ2 ’21: $4.0BQ3 ’21: $3.1BQ4 ’21: $2.8BQ4 ’21Q1 ’22: $2.3BQ2 ’22: $1.4BQ3 ’22: $1.8BQ4 ’22: $2.0BQ4 ’22Q1 ’23: $2.3BQ2 ’23: $2.9BQ3 ’23: $2.8BQ4 ’23: $3.4BQ4 ’23Q1 ’24: $4.4BQ2 ’24: $2.9BQ3 ’24: $3.0BQ4 ’24: $3.7BQ4 ’24Q1 ’25: $3.1BQ2 ’25: $4.1BQ3 ’25: $4.1BQ4 ’25: $4.5BQ4 ’25Q1 ’26: $3.4Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 79.6%ADR: 18.8%ETP: 1.2%Other: 0.4%
  • Common Stock · 79.6% · $2.4B
  • ADR · 18.8% · $576M
  • ETP · 1.2% · $36M
  • Other · 0.4% · $12M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
DOCUDocusign IncNEW+1.07M1.07M+$87M$87M
CCCCcc Intelligent Solutions HlNEW+5.60M5.60M+$51M$51M
EQTEqt CorpNEW+859.3K859.3K+$46M$46M
CZRCaesars Entertainment Inc NeNEW+1.55M1.55M+$39M$39M
TWLOTwilio IncNEW+362.2K362.2K+$35M$35M
COFCapital One Finl CorpNEW+197.7K197.7K+$35M$35M
ROKURoku IncNEW+493.6K493.6K+$35M$35M
BBIOBridgebio Pharma IncNEW+438.1K438.1K+$15M$15M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2025

49 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NTRANatera Inchistory →COM15.72%$481M3.40M
2TEVATeva Pharmaceutical Inds Ltdhistory →SPONSORED ADS7.47%$229M14.88M
3CPNGCoupang Inchistory →CL A6.67%$204M9.30M
4WWDWoodward Inchistory →COM6.55%$200M1.10M
5PMPhilip Morris Intl Inchistory →COM5.73%$175M1.11M
6COHRCoherent Corphistory →COM4.72%$144M2.22M
7MELIMercadolibre Inchistory →COM3.43%$105M53.7K
8INSMInsmed Inchistory →COM PAR $.013.41%$104M1.37M
9TSMTaiwan Semiconductor Mfg Ltdhistory →SPONSORED ADS3.25%$99M598.8K
10DOCUDocusign Inchistory →COM2.86%$87M1.07M
11FLUTFlutter Entmt Plchistory →SHS2.73%$84M377.5K
12LLYEli Lilly & Cohistory →COM2.56%$78M94.8K
13YPFYpf Sociedad Anonimahistory →SPON ADR CL D2.38%$73M2.08M
14VRNAVerona Pharma Plchistory →SPONSORED ADS2.08%$64M1.00M
15BCSBarclays Plchistory →ADR1.92%$59M3.82M
16WABWabtechistory →COM1.78%$55M301.1K
17CCCCcc Intelligent Solutions Hlhistory →COM1.65%$51M5.60M
18KMIKinder Morgan Inc Delhistory →COM1.54%$47M1.65M
19EQTEqt Corphistory →COM1.50%$46M859.3K
20CZRCaesars Entertainment Inc Nehistory →COM1.27%$39M1.55M
21FCXFreeport-Mcmoran Inchistory →CL B1.26%$39M1.02M
22DAKTDaktronics Inchistory →COM1.22%$37M3.07M
23ARGTGlobal X Fdshistory →GB MSCI AR ETF1.17%$36M443.8K
24TWLOTwilio Inchistory →CL A1.16%$35M362.2K
25COFCapital One Finl Corphistory →COM1.16%$35M197.7K
26ROKURoku Inchistory →COM CL A1.14%$35M493.6K
27BMABanco Macro Sahistory →SPON ADR B1.07%$33M431.8K
28Springworks Therapeutics IncCOM0.89%$27M615.9K
29AMZNAmazon Com Inchistory →COM0.85%$26M136.8K
30UALUnited Airls Hldgs Inchistory →COM0.83%$25M368.7K
31ASNDAscendis Pharma A/Shistory →SPONSORED ADR0.81%$25M158.7K
32PCTPurecycle Technologies Inchistory →COM0.76%$23M3.36M
33GGALGrupo Financiero Galicia S.Ahistory →SPONSORED ADR0.68%$21M381.5K
34STXSeagate Technology Hldngs Plhistory →ORD SHS0.61%$19M219.5K
35BNBrookfield Corphistory →CL A LTD VT SH0.54%$17M315.9K
36NAMSNewamsterdam Pharma Companyhistory →ORDINARY SHARES0.54%$16M800.4K
37TECKTeck Resources Ltdhistory →CL B0.51%$16M431.5K
38BBIOBridgebio Pharma Inchistory →COM0.49%$15M438.1K
39DALDelta Air Lines Inc Delhistory →COM NEW0.49%$15M345.1K
40Flex LtdORD0.38%$12M348.9K
41EXEExpand Energy Corporationhistory →COM0.36%$11M97.7K
42APPApplovin Corphistory →COM CL A0.35%$11M40.2K
43ARAntero Resources Corphistory →COM0.34%$10M258.4K
44PIImpinj Inchistory →COM0.32%$10M108.5K
45TSLATesla Inchistory →COM0.16%$5M18.8K
46RAREUltragenyx Pharmaceutical Inhistory →COM0.10%$3M85.4K
47AALAmerican Airlhistory →S GROUP INC COM0.05%$1M133.7K
48IVVDInvivyd Inchistory →COM0.01%$346,000571.4K
49JOBYJoby Aviation Inchistory →COMMON STOCK0.01%$190,00031.5K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$3.4B70May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$4.5B62Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$4.1B65Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$4.1B69Aug 15, 202513F-HRchanges · EDGAR ↗
Q1 2025$3.1B52May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$3.7B78Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$3.0B75Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.9B64Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$4.4B73May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$3.4B51Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.8B41Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.9B53Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.3B48May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.0B58Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.8B65Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$2.3B51May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$2.8B49Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$3.1B49Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021REVEALED$4.0B52Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021REVEALED$4.5B64May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$3.7B56Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$3.4B61Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B72Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.5B46May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$3.4B62Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.6B43Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.4B61Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$3.4B61May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.7B31Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.